VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge UJ926AD

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
MA 6 FL 1 CA 1 AZ 1 IL 1 TX 1 NY 1

VAERS 2536049

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj926ad

kritisch
Staat
-
Alter
83,0
Geschlecht
M
Eingang
17.12.2022
Impfdatum
07.12.2022
Beginn
16.12.2022
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Alanine aminotransferase normal Anion gap Anticoagulant therapy Aspartate aminotransferase normal Asthenia Bacterial test positive Basophil count decreased Basophil percentage decreased Bilirubin urine Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin increased Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood lactic acid normal Blood potassium normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: on December 16, 2022 17:46 Verified By: on December 16, 2022 18:03 Encounter Info: Emergency, 12/16/22 - 12/16/22 * Final Report * Document Contains Addenda Chief Complaint Altered mental status History of Present Illness/Subjective This is a 83 year old patient with a past medical history significant for Hx of benign prostatic hypertrophy, Abdominal aortic aneurysm, AF (atrial fibrillation), Gilbert's disease, Renal stones, Stroke, Anemia, Myocardial infarction, Major depression, that presented to ED from home with c/o altered mental status and is being admitted to inpatient for UTI. This patient was seen and evaluated while still in ED. He was found to be lying in bed, alert and in no distress. His wife is present at bedside and providing most of his history. She states that he was at his baseline yesterday and this morning he started vomiting was acting somewhat confused and disoriented. He is weak and needing assistance with ambulation. She said this is quite similar to an episode he had in October where he needed admission to the hospital for UTI. He does have known frequent UTIs. They tend to be all multidrug-resistant and need IV antibiotics. He has had no falls or head trauma. He has had no new medications. Vs stable. WBC wnl. Hgb 11.5. BUN 31, Cr 1.60, Glucose 153, bilirubin 1.6, protein 8.3. CXR shows Coarse interstitial opacities are noted in the mid and lower lung zones bilaterally. This is indeterminant and could be a chronic finding. Interstitial edema or an atypical infectious/inflammatory process could also appear similarly. Covid and flu negative. Large leuks and nitrite pos in urine. Review of Systems Constitutional: No fevers, no chills, no sweats Eyes: No changes in vision Ears, Nose, Mouth, Throat: No ear pain, no nasal congestion, no sore throat Respiratory: No shortness of breath, no cough, no wheeze Cardiovascular: No chest pain, no palpitations, no edema Gastrointestinal: No abdominal pain, + nausea, + vomiting, no diarrhea, no constipation Genitourinary: No frequency, no urgency, no dysuria, no hematuria Hematologic/Lymphatic: No bruising, no enlarged lymph nodes Allergic/Immunologic: No hives Endocrine: No cold intolerance, no heat intolerance, no polyuria, no polydipsia Musculoskeletal: No arthralgia, no myalgia Skin: No rash, no pruritus Neurological: No headache, no focal weakness, no numbness +confusion Psychiatric: No anxiety, no depression Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) Temp (CEL) 36.5 (36.5-36.5) Temp (FAHR) 97.7 (97.7-97.7), BP 129/60 (129-132)/(60-82), HR 92 (92-94), RR 22 (22-22), O2Sat 97 (97-97) Patient Weight Current Daily Weight: 107.7 kg 12/16/22 Patient Height Current Height: 182.39 cm 12/16/22 Constitutional: No acute distress, well-nourished Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Mild cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan This is a 83 year old patient with a past medical history significant for Hx of benign prostatic hypertrophy, Abdominal aortic aneurysm, AF (atrial fibrillation), Gilbert's disease, Renal stones, Stroke, Anemia, Myocardial infarction, Major depression, that presented to ED from home with c/o altered mental status and is being admitted to inpatient for UTI. 1. UTI (urinary tract infection) N39.0 acute on chronic does not meet sepsis criteria Pos urine culture with hx of ESBL that is multidrug resistant including carbapenems. Gentamicin given in ED. will continue with this. follows with dr. hx of bph and urinary retention holding on fluids given pulm edema noted on cxr and hx of CHF. 2. Encephalopathy G93.40 likely 2/2 above 3. Pneumonia J18.9 procal, Respiratory culture/stain, Legionella antigen, and strep pneumoniae antigen, and blood cx pending Could possibly be from aspiration as he was vomiting. Will cover with cefepime and Flagyl and obtain ST consult will will add doxy to cover atypicals, will deescalate antibiotics as appropriate RT eval keep O2 sats at or above 92% -- > currently 97% on RA supplemental O2 prn 4. Pulmonary edema J81.1 continue home lasix previous echo in 2019 was nonactionable new echo pending 5. Weakness R53.1 2/2 above PT/OT eval 6. AF (atrial fibrillation) I48.91 rate controlled cotinue home metoprolol and apixaban -- > changed dose to renal dosing 7. Anemia D64.9 stable and at baseline, will monitor 8. CVA (cerebrovascular accident) I63.9 noted 9. Chronic diastolic congestive heart failure I50.32 continue spironolactone 10. Depression F32.A continue home Cymbalta 11. GERD (gastroesophageal reflux disease) K21.9 resume home ppi 12. Hyperlipidemia E78.5 resume home statin 13. Hypertension I10 stable resume home meds 14. Hypothyroidism E03.9 resume home levothyroxine 15. On anticoagulant therapy Z79.01 resume home apixaban 16. Recurrent falls R29.6 pt/ot eval fall risk precautions 17. Stage 3 chronic kidney disease N18.30 noted and at baseline renally dose medications and avoid nephrotoxins 18. Type 2 diabetes mellitus with renal complication E11.29 AC and HS blood sugar checks with sliding scale. Carb controlled diet hold home oral meds 19. Monoclonal gammopathy D47.2 noted 20. Nausea and vomiting R11.2 likely d/t UTI zofran prn Inpatient, medical floor Daily labs - CBC, CMP Daily Low Carb Diet IV fluids SL Full Code VTE Prophylaxis - Fully anticoagulated with apixaban Code Status None Recorded Chronic Problem List Anemia Atrial fibrillation, chronic Chronic diastolic congestive heart failure CVA (cerebrovascular accident) Depression GERD (gastroesophageal reflux disease) History of arterial ischemic stroke Hyperlipidemia Hypertension Hypothyroidism Monoclonal gammopathy On anticoagulant therapy Recurrent falls Stage 3 chronic kidney disease Type 2 diabetes mellitus with renal complication Procedure/Surgical History ?Esophagogastroduodenoscopy (01/04/2019) ?Appendectomy ?Hernia repair ?Procedure on bladder ?TURP Surgical History Internal 01/04/2019 EGD Bx 10/14/2013 Prostatectomy HoLEP Medications Home Medications (17) Active Aldactone 25 mg oral tablet 25 mg = 1 Tablet, Orally, Daily Anoro Ellipta 62.5 mCg-25 mCg inhalation powder 1 Puff, Inhalation, Daily apixaban 5 mg oral tablet 5 mg = 1 Tablet, Orally, BID Blood Glucose Meter See Instructions, Tests twice dailyE11.9 Blood Glucose Test Strips See Instructions, Pt tests twice dailyE11.9 Contour Next Test Strips See Instructions, Use to test blood sugar TIDDX: E11.9 Cymbalta 60 mg oral delayed release capsule 60 mg = 1 Capsule, Orally, Daily, do not crush or chew Wheelchair Not Applicable, Other, Unscheduled, I63.9R29.6R26.81 glipiZIDE-metFORMIN 2.5 mg-250 mg oral tablet 1 Tablet, Orally, BID Lancet Device See Instructions, Tests twice dailyE11.9 Lancets See Instructions, Tests twice dailyE11.9 Lasix 40 mg oral tablet 40 mg = 1 Tablet, Orally, 3x/WK Lipitor 40 mg oral tablet 40 mg = 1 Tablet, Orally, At Bedtime ProAir HFA 90 mCg/inh inhalation aerosol 2 Puff, PRN, Inhalation, Q4H Protonix 40 mg oral delayed release tablet 40 mg = 1 Tablet, Orally, Daily Synthroid 125 mCg (0.125 mg) oral tablet 125 mCg = 1 Tablet, Orally, Daily Toprol-XL 25 mg oral tablet, extended release 25 mg = 1 Tablet, Orally, BID Active Scheduled Inpatient Medications None Reported One-Time Medications Given 12/15/22 00:00:00 TO 12/16/22 17:46:24 gentamicin, Injection, 560 mg, IVPB, ONCE, (1 DOSE 12/16/22 17:39:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 12/16/22 14:57:00) PRN Medications (0600 - 0559) from 12/15 - 12/16 None Reported Allergies Contrast Dye (Anaphylaxis, Fainting) penicillins (hives) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Diabetes mellitus type 1: Father. Diabetes mellitus type 2: Sister. Heart disease..: Father. Hypertension: Sister. Prostate cancer: Child. Stroke: Mother and Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 7.4 k/cumm (12/16/22 14:19:00) RBC: 3.97 million/cumm Low (12/16/22 14:19:00) Hgb: 11.5 GM/dL Low (12/16/22 14:19:00) Hct: 34.4 % Low (12/16/22 14:19:00) MCV: 87 fL (12/16/22 14:19:00) MCH: 28.9 pg (12/16/22 14:19:00) MCHC: 33.4 GM/dL (12/16/22 14:19:00) RDW: 14.3 % (12/16/22 14:19:00) Platelet: 223 k/cumm (12/16/22 14:19:00) MPV: 7.1 fL (12/16/22 14:19:00) Neutrophils %: 78 % (12/16/22 14:19:00) Lymphocytes %: 16 % (12/16/22 14:19:00) Monocytes %: 4 % (12/16/22 14:19:00) Eosinophils %: 2 % (12/16/22 14:19:00) Basophils %: 0 % (12/16/22 14:19:00) Absolute Neutrophil: 5.7 k/cumm (12/16/22 14:19:00) Absolute Lymphocyte: 1.2 k/cumm (12/16/22 14:19:00) Absolute Monocyte: 0.3 k/cumm (12/16/22 14:19:00) Absolute Eosinophil: 0.1 k/cumm (12/16/22 14:19:00) Absolute Basophil: 0 k/cumm (12/16/22 14:19:00) Chemistry: Sodium SerPl QN: 138 mmol/L (12/16/22 14:19:00) Potassium SerPl QN: 4.5 mmol/L (12/16/22 14:19:00) Chloride SerPl QN: 100 mmol/L (12/16/22 14:19:00) Carbon Dioxide SerPl QN: 27 mmol/L (12/16/22 14:19:00) Anion Gap: 11 mmol/L (12/16/22 14:19:00) BUN SerPl QN: 31 mg/dL High (12/16/22 14:19:00) Creatinine SerPl QN: 1.6 mg/dL High (12/16/22 14:19:00) Estimated GFR (CKD-EPI, no race): 42 mL/min/1.73m2 Low (12/16/22 14:19:00) Estimated CRCL (CG): 45 mL/min Low (12/16/22 14:19:00) Glucose SerPl QN: 153 mg/dL High (12/16/22 14:19:00) Calcium Total SerPl QN: 10 mg/dL (12/16/22 14:19:00) Alkaline Phos SerPl QN: 82 Units/L (12/16/22 14:19:00) ALT SerPl QN: 7 Units/L (12/16/22 14:19:00) AST SerPl QN: 10 Units/L Low (12/16/22 14:19:00) Bilirubin Total SerPl QN: 1.6 mg/dL High (12/16/22 14:19:00) Total Protein SerPl QN: 8.3 GM/dL High (12/16/22 14:19:00) Albumin SerPl QN: 4.1 GM/dL (12/16/22 14:19:00) Lactate Venous Pl QN: 1.9 mmol/L (12/16/22 14:19:00) Urine Studies: Color: Yellow (12/16/22 15:40:00) Clarity: Clear (12/16/22 15:40:00) Specific Gravity: 1.015 (12/16/22 15:40:00) pH: 6.5 (12/16/22 15:40:00) Protein: NEGATIVE (12/16/22 15:40:00) Glucose: NEGATIVE (12/16/22 15:40:00) Ketones: NEGATIVE (12/16/22 15:40:00) Bilirubin: NEGATIVE (12/16/22 15:40:00) Hgb Ur: SMALL. Abnormal (12/16/22 15:40:00) Nitrite: POSITIVE Abnormal (12/16/22 15:40:00) Urobilinogen: 1.0. (12/16/22 15:40:00) Leukocyte Esterase Ur: LARGE. Abnormal (12/16/22 15:40:00) WBC: 21-50 Abnormal (12/16/22 15:40:00) RBC: 11-20 Abnormal (12/16/22 15:40:00) Bacteria: Moderate Abnormal (12/16/22 15:40:00) Squamous Epithelial: Few (12/16/22 15:40:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (12/16/22 14:19:00) Coronavirus SARS-CoV2 Rapid: Not Detected (12/16/22 14:19:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (12/16/22 14:19:00) Rapid Influenza A PCR: Not Detected (12/16/22 14:19:00) Rapid Influenza B PCR: Not Detected (12/16/22 14:19:00) Diagnostics Radiology Results - Last 24 hours Across Visits 12/16/2022 16:03 - XR Chest PA or AP Portable IMPRESSION:1. Coarse interstitial opacities are noted in the mid and lower lungzones bilaterally. This is indeterminant and could be a chronicfinding. Interstitial edema or an atypical infectious/inflammatoryprocess could also appear similarly.Thank you for consulting our team of subspecialty radiologists. Healthcare providers wishing to discussthis case further can contact. For after-hours or emergency department cases. Signature Line Electronically Signed on 12/16/22 18:03 ________________________________________________________ Addendum on December 16, 2022 18:13:58 (Verified) General: Alert and oriented, No Acute distress Eye: Pupils are equal, round and reactive to light HEENT: Normocephalic, atraumatic Neck: Supple, normal range of motion Oropharynx: No erythema or drainage. Respiratory: Lungs are clear to auscultation. No added sounds Cardiovascular: Normal rate, Regular rhythm. s1 s2 positive Gastrointestinal: Soft, Non-tender. BS present all 4 quadrants Musculoskeletal: Normal range of motion, No focal tenderness Integumentary: Warm, Dry, No rash Neurologic: No focal weakness. Sensation intact. Normal mood and affect. cranial nerves grossly intact I saw and evaluated the patient in addition to the APP. I provided a substantive portion of the care for this patient. I personally performed in its entirety examfor this encounter. I have reviewed and verified this documentation and it accurately reflects our care. Hospital Medicine Signature Line Electronically Signed on 12/16/22 18:14 ________________________________________________________

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Hemogram-Platelets-WBC Differential 8.5 k/cumm 7.4 k/cumm (L) 3.71 million/cumm (L) 3.97 million/cumm (L) 10.6 GM/dL (L) 11.5 GM/dL (L) 32.3 % (L) 34.4 % 87 fL 87 fL 28.7 pg 28.9 pg 32.9 GM/dL 33.4 GM/dL (H) 14.8 % 14.3 % 209 k/cumm 223 k/cumm 7.1 fL 7.1 fL 75 % 78 % 18 % 16 % 6 % 4 % 1 % 2 % 0 % 0 % 6.4 k/cumm 5.7 k/cumm 1.5 k/cumm 1.2 k/cumm 0.5 k/cumm 0.3 k/cumm 0.1 k/cumm 0.1 k/cumm 0.0 k/cumm 0.0 k/cumm Routine Chemistry Tests 140 mmol/L 138 mmol/L 4.6 mmol/L 4.5 mmol/L 102 mmol/L 100 mmol/L 27 mmol/L 27 mmol/L 11 mmol/L 11 mmol/L (H) 28 mg/dL (H) 31 mg/dL (H) 1.70 mg/dL (H) 1.60 mg/dL * (L) 40 mL/min/1.73m2 * (L) 42 mL/min/1.73m2 * (L) 42 mL/min * (L) 45 mL/min (H) 133 mg/dL (H) 153 mg/dL * (H) 135 mg/dL * (H) 138 mg/dL * (H) 116 mg/dL * (H) 129 mg/dL 9.7 mg/dL 10.0 mg/dL 76 Units/L 82 Units/L (L) 6 Units/L 7 Units/L 13 Units/L (L) 10 Units/L (H) 1.8 mg/dL (H) 1.6 mg/dL * 8.0 GM/dL * (H) 8.3 GM/dL 4.0 GM/dL 4.1 GM/dL 1.9 mmol/L Urinalysis Color Yellow Clarity Clear Specific Gravity 1.015 pH 6.5 Protein Negative mg/dL Glucose Negative mg/dL Ketones Negative mg/dL Bilirubin * Negative mg/dL Hgb Ur (A) Small Nitrite (A) Positive Urobilinogen * Normal mg/dL Leukocyte Esterase Ur (A) Large WBC (A) 21-50 /hpf RBC (A) 11-20 /hpf Bacteria (A) Moderate /hpf Squamous Epithelial Few /hpf Molecular Diagnostic Tests COVID 19 Specimen Source Nasopharyngeal Coronavirus SARS-CoV2 Rapid * Not Detected Viral FS Rapid Influenza Method PCR Rapid Influenza A PCR * Not Detected Rapid Influenza B PCR * Not Detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728003

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UJ926AD

moderat
Staat
FL
Alter
71,0
Geschlecht
F
Eingang
28.12.2023
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Acute motor-sensory axonal neuropathy Albumin globulin ratio increased Albumin globulin ratio normal Amino acid level Anion gap Antineutrophil cytoplasmic antibody negative Antineutrophil cytoplasmic antibody positive Anxiety Aspartate aminotransferase normal Balance disorder Basophil count decreased Basophil percentage Biopsy Biopsy skin Blood 25-hydroxycholecalciferol Blood albumin normal Blood alkaline phosphatase normal Blood arsenic increased

Symptomtext

That evening (10-24-22) I experienced significant burning in both feet & both hands. It escalated over the next week and the burning spread to hands and face with tingling also in both arms and both legs. Toes, bottom of feet and finger tips became numb. Significant itching and random needle stick pains. Fatigue, insomnia, brain fog, ANXIETY, & some balance issues!!. 10-24 - Dr. visit 10/31 - Dr telephone 11/1 - Dr - office Tried gabapentin - 3 months. 11/1/22 office visit Dr prednisone - 30mg reported symptoms 11/11/ Dr. - Neurology possible acute neuritis due to flu shot 11/21 EMG Tried gabapentin 300mg up to 900mg - too many side effects so stopped.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
See continue page
Aktuelle Erkrankungen
-none
Vorgeschichte
-none
Andere Medikamente
Fish oil, Flax Seed oil
Allergien
-none
Vorherige Impfungen
-

VAERS 2481610

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

moderat
Staat
MA
Alter
81,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
13.10.2022
Beginn
16.10.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain in extremity

Symptomtext

High Dose Flu vaccine was administered on Thursday, October 13, 2022, onset of symptoms began on Saturday, October 15, 2022, starting in the afternoon and progressively getting worse throughout the day. He c/o decrease ROM in his Left Arm, having difficulty putting his arm over his head, c/o of his arm aching. He's been taking 200mg of Advil 5x day with good effect. Seeing his PCP today at 11:30 am for this current issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Today is his PCP appointment to address the lack of ROM in his left arm. Taking 200mg 5x day.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Multivitamin daily Omega 3 supplement daily
Allergien
None
Vorherige Impfungen
-

VAERS 2507218

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

mild
Staat
CA
Alter
69,0
Geschlecht
M
Eingang
14.11.2022
Impfdatum
09.11.2022
Beginn
10.11.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of personal independence in daily activities Nausea Retching

Symptomtext

Patient reports experiencing some dizziness the following morning at 7 am. It seem to worsen by 9 am to such a point that it caused nausea and dry heaving requiring him to have someone help him return home from work. Symptoms lasted almost 2 days progressively getting a little better and patient reports finally feeling "normal" on 11/11/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None reported
Aktuelle Erkrankungen
Patient denies any short-term illnesses at the time of vaccination and up to one month prior
Vorgeschichte
Hypertension, Hypercholesterolemia, Enlarged Prostate
Andere Medikamente
None reported
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 2501954

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj926ad

mild
Staat
AZ
Alter
72,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
04.11.2022
Beginn
05.11.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ear pain Erythema Peripheral swelling

Symptomtext

Sharp pain in left ear, coming in waves, with severity waxing and waning,. Second episode following 20 minutes after first, then becoming more frequent, until about 4 minutes apart. Then becoming less frequent. Pain subsided by 6 PM. Also, mild redness and swelling of left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ear pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Post viral meningitis (2011) with occasional pain in left ear. Pain probably neurogenic in origin.
Andere Medikamente
Thyroxin
Allergien
Ibuprofen
Vorherige Impfungen
-

VAERS 2495213

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

mild
Staat
IL
Alter
77,0
Geschlecht
F
Eingang
01.11.2022
Impfdatum
27.10.2022
Beginn
27.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Swelling face

Symptomtext

Patient reported that she began to have an itchy and swollen face approximately five hours after receiving her COVID bivalent booster and high dose flu vaccine. She denied a rash. Also denied difficulty breathing and any other symptoms. She did not contact her doctor but has been taking Benadryl since the episode. Continued to have an itchy and swollen face on 10/31/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
None - patient did not report the event to her doctor.
Aktuelle Erkrankungen
-
Vorgeschichte
Psoriatic arthritis
Andere Medikamente
Enbrel
Allergien
Heparin, Humira, Methotrexate, Neomycin, Gold, N95 masks, Pantene conditioner
Vorherige Impfungen
-

VAERS 2481616

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

mild
Staat
MA
Alter
79,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
13.10.2022
Beginn
14.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain

Symptomtext

Onset of symptoms began on October 14, 2022 with soreness and redness below the injection site, with a "wide" band of redness for a total of 2 days, which resolved on October 16. She stated "this hasn't happened before, after an injection"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
aortic aneurysm 6 years ago
Andere Medikamente
Metoprolol ER 100 mg daily Lisinopril 2.5 mg daily Xarelto 20 mg daily Multivitamin once daily Vit D daily
Allergien
none
Vorherige Impfungen
-

VAERS 2473058

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

mild
Staat
TX
Alter
69,0
Geschlecht
F
Eingang
09.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

Patient reported hives on legs 2 hours after vaccination. She took benadryl and applied hydrocortisone and hives eventually went away

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
PENICILLIN
Vorherige Impfungen
-

VAERS 2501370

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

gering
Staat
NY
Alter
86,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
07.10.2022
Beginn
28.10.2022
Tage bis Beginn
21,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

patients received a FLUZONE QIV HD dose earlier in October, and inadvertently received another during their visit today. with no reported adverse event; Initial information received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves an 86-year-old female patient who had received a INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] dose earlier in October, and inadvertently received another during their visit today. with no reported adverse. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received 0.7ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (strength, formulation: unknown) (lot number: UJ926AD and expiry date: 30-Jun-2023) via intramuscular route in unknown administration site. On 28-Oct-2022 she also received 0.7ml dose of the same vaccine lot UJ926AD via intramuscular route in the right deltoid for Immunization. On 28-Oct-2022, a non-serious event occurred, patient received a fluzone qiv hd dose earlier in October, and inadvertently received another during their visit today. with no reported adverse event (extra dose administered) (latency: 21 days). It was reported, They are asking what needs to be done in the case of an extra dose such as this?. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2476501

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj926ad

gering
Staat
-
Alter
83,0
Geschlecht
F
Eingang
12.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Syringe issue

Symptomtext

After needle was inserted into muscle the "push" mechanism on the syringe froze and would not deliver the liquid contents into the patient's arm. The needle and syringe were removed and examined...looked ok but could not push the liquid out of the needle. The patient agreed to a second needle stick in the same arm and a new dose of vaccine was obtained from the refrigerator. The second dose was administered successfully. Attempts to follow up with the patient 2 days later were unsuccessful so it is not know if there were any adverse effects from the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syringe issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472800

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

gering
Staat
MA
Alter
90,0
Geschlecht
M
Eingang
09.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered No adverse event

Symptomtext

PATIENT WAS GIVEN PFIZER-BIONTECH VACCINE WHEN IT SHOULD OF BEEN THE PFIZER-BIONTECH BIVALENT VACCINE. PATIENT REPORTED NO ADVERSE EFFECTS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472686

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

gering
Staat
MA
Alter
75,0
Geschlecht
M
Eingang
08.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

PFIZER BIONTECH WAS GIVEN BUT SHOULD OF BEEN THE PFIZER-BIONTECH BIVALENT VACCINE. NO ADVERSE EVENTS REPORTED

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472680

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

gering
Staat
MA
Alter
79,0
Geschlecht
M
Eingang
08.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered No adverse event

Symptomtext

PFIZER BIONTECH WAS GIVEN BUT SHOULD OF BEEN THE PFIZER-BIONTECH BIVALENT VACCINE. NO ADVERSE EVENTS REPORTED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472679

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ926AD

gering
Staat
MA
Alter
74,0
Geschlecht
M
Eingang
08.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

PFIZER BIONTECH WAS GIVEN BUT SHOULD OF BEEN THE PFIZER-BIONTECH BIVALENT VACCINE. NO ADVERSE EVENTS REPORTED

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-